2 recruiting, 1 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
Follow Recurrent Solid Tumor: new trials by email Literature Review of Recurrent Solid Tumor trials Research Report on Recurrent Solid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer [177Lu]Lu-SN201 - Solid Tumor, Metastatic Cancer | Phase 1 / Phase 2 | Recruiting | Spago Nanomedical AB | 90 | 2023-12-06 | 2025-11-20 |
| Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma Onivyde, Talazoparib, Temozolomide - Recurrent Solid Tumor, Recurrent Ewing Sarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 90 | 2021-06-09 | 2026-05-19 |
| A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer NT219, NT219 and ERBITUX® - Dose Escalation, NT219 and ERBITUX® - Expansion - Solid Tumor, Adult, Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | Completed | TyrNovo Ltd. | 52 | 2020-09-03 | 2024-09-19 |
Neoplasm Metastasis (2) · Neoplasms (2) · Head and Neck Neoplasms (1) · Hepatoblastoma (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Osteosarcoma (1) · Rhabdoid Tumor (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Ewing (1) · Squamous Cell Carcinoma of Head and Neck (1) · Wilms Tumor (1)
Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1)
Temozolomide (1) · irinotecan sucrosofate (1) · talazoparib (1)
Spago Nanomedical AB (1) · St. Jude Children's Research Hospital (1) · TyrNovo Ltd. (1)
United States (2) · Australia (1) · Canada (1) · Israel (1)
Kim Taubman (1) · Michael Schickler, PhD (1) · Sara Federico, MD (1)